Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension

被引：0

作者：

Massimo Volpe

Alejandro de la Sierra

Bettina Ammentorp

Petra Laeis

机构：

[1] University of Rome “La Sapienza”,Division of Cardiology, Department of Clinical and Molecular Medicine

[2] Sant’Andrea Hospital,Department of Internal Medicine, Hospital Mutua Terrassa

[3] IRCCS Neuromed,undefined

[4] University of Barcelona,undefined

[5] Daiichi Sankyo Europe GmbH,undefined

来源：

Advances in Therapy | 2014年 / 31卷

关键词：

Cardiology; Hypertension; Olmesartan/amlodipine/hydrochlorothiazide; Open-label; Seated diastolic blood pressure; Seated systolic blood pressure; Triple combination;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：561 / 574

页数：13

共 50 条

[21] Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
Ruilope, Luis M.
VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (06) : 1237 - 1248
[22] Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study
Neutel, Joel M.
Giles, Thomas D.
Punzi, Henry
Weiss, Robert J.
Li, Huiling
Finck, Amy
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2014, 8 (12) : 915 - 920
[23] Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study (vol 6, pg 132, 2012)
Chrysant, Steven G.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2013, 7 (04) : 325 - 325
[24] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
Leonardi, Craig
Strober, Bruce
Gottlieb, Alice B.
Elewski, Boni E.
Ortonne, Jean-Paul
van de Kerkhof, Peter
Chiou, Chiun-Fang
Dunn, Meleana
Jahreis, Angelika
JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
[25] Long-term efficacy and safety with zonisamide: Interim analysis of an open-label study
Wroe, S
Brodie, MJ
EPILEPSIA, 2005, 46 : 118 - 118
[26] EFFICACY AND SAFETY OF ALISKIREN/AMLODIPINE OR ALISKIREN/AMLODIPINE/HYDROCHLOROTHIAZIDE COMBINATIONS: A 18-WEEK, OPEN-LABEL STUDY IN PATIENTS WITH STAGE II HYPERTENSION IN THAILAND
Vichairuangthum, Kitigon
Chotnaparatpat, Paiboon
JOURNAL OF HYPERTENSION, 2015, 33 : E5 - E5
[27] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
David A. Calhoun
Nora A. Crikelair
Joseph Yen
Robert D. Glazer
Advances in Therapy, 2009, 26 : 1012 - 1023
[28] COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION .2. AN OPEN LONG-TERM STUDY OF EFFICACY AND SAFETY
HEIDBREDER, D
FROER, KL
BAUER, B
CAIRNS, V
BREITSTADT, A
BENDER, N
CLINICAL CARDIOLOGY, 1993, 16 (01) : 47 - 52
[29] Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety
Calhoun, David A.
Crikelair, Nora A.
Yen, Joseph
Glazer, Robert D.
ADVANCES IN THERAPY, 2009, 26 (11) : 1012 - 1023
[30] Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study
Philipp, Thomas
Glazer, Robert D.
Zhao, Yanxing
Pospiech, Rainer
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 187 - 193

← 1 2 3 4 5 →